Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of the Effect of Adjuvant Treatment With Capecitabine in Combination With Oxaliplatin on Disease-Free Survival in Patients With Stage III Colon Cancer

NCT01442155 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01442155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01442155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of the Effect of Adjuvant Treatment With Capecitabine in Combination With Oxaliplatin on Disease-Free Survival in Patients With Stage III Colon Cancer
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
April 30, 2015
Enrollment
74 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer